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depression using a simple economic game
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Gregor Hasler
Background
Price’s social competition hypothesis interprets the depressive
state as an unconscious, involuntary losing strategy, which
enables individuals to yield and accept defeat in competitive
situations.
Aims
We investigated whether patients who suffer from major
depressive disorder (MDD) would avoid competition more often
than either patients suffering from borderline personality
disorder (BPD) or healthy controls.
Method
In a simple paper-folding task healthy participants and patiens
with MDD and BPD were matched with two opponents, one
with an unknown diagnosis and one who shared their clinical
diagnosis, and they had to choose either a competitive or
cooperative payment scheme for task completion.
Results
When playing against an unknown opponent, but not the
opponent with the same diagnosis, the patients with depression
chose the competitive payment scheme statistically less often
than healthy controls and patients diagnosed with BPD.
Conclusion
The competition avoidance against the unknown opponent is
consistent with Price’s social competition hypothesis.
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Major depressive disorder (MDD) represents a significant and
common cause of social impairment1 and is one of the leading
global causes of disability-adjusted life-years.2 Even during the
remission phase of the illness, patients who previously suffered
from depression show impairments in psychosocial domains,3 like
the inability to socialise,4,5 negative interactions with their spouse
and more family conflicts.6–9 Depression limits activities of daily
living at home and school, resulting in higher unemployment10 and
adverse social outcomes such as reduced educational attainment,
increased likelihood of teenage parenthood andmarital instability.11–14
The reasons behind social impairments are not well understood,15
and the results of previous studies on social cooperation in
depression applying simple economic games have been inconclu-
sive. Although some studies have suggested that depressive symp‐
toms relate to an uncooperative pattern of response, like making
fewer altruistic responses in a trust game16 or offering lower
contributions in a public goods game,17 others have shown the
opposite pattern. For instance, it has been demonstrated that
in the prisoner’s dilemma game, patients with depression respond
more cooperatively to overtures from their co-players than do
controls.18
Since depression is so commonly observed across the world,
an increasing number of researchers have attempted to explain
it and social impairments caused by it from the perspective of
evolutionary adaptations.19–22 One of the leading theories, the
social competition theory, interprets depression as an appease-
ment display inherited from our ancestors as a mechanism for
yielding in competitive situations.21 When chances of winning in a
social competition are low, the involuntary subordinate strategy
prevents the individual with depression from attempting to make
a comeback and inhibits aggressive behaviour towards rivals through
communicating a non-combative status by displaying submissive
and affiliative behaviour. Thus, although the individual gives up
any chance of winning, he also reduces the damage caused by a
potential loss.20 This theory is supported by clinical evidence
showing that episodes of depression are precipitated by social
competition and are resolved by reconciliation.23,24 Additionally,
research has shown that treating submissive animals with an anti‐
depressant significantly reduces submissive behaviour.25,26 Despite
this evidence, we found no published studies that experimentally
tested whether patients with depression avoid competing more
than healthy individuals in the same context.
In this paper, we use an economic experiment that simulates
real-life interactions in controlled settings using monetary incentives.
Such economic experiments have been used not only to study
economic situations but, increasingly, also to investigate people’s
willingness to either cooperate27 or compete.28 Specifically, our
participants performed a real effort task and could choose between
using a competitive or a cooperative payment scheme. This allowed
us to investigate the differences in competitiveness between patients
with MDD and healthy controls.
Based on the social competition hypothesis,20 we hypothesised
that in a simple economic experiment, patients with MDD would
avoid competitive situations significantly more often than healthy
controls and patients with borderline personality disorder (BPD).
To control for differences in the subjective estimations of the
opponent’s performance, we conducted two experiments in which
participants needed to decide in favour of either cooperating with
or competing against an opponent with no, or an unknown,
diagnosis (Experiment I) and an opponent with the same
diagnosis as the participant (Experiment II). They chose to either
compete or cooperate before performing a task. To examine the
emotional correlates of competitive behaviours, we established six
fictitious scenarios describing different game outcomes and asked
the participants at the end of the experiment to report their
positive and negative emotions to these scenarios.
To test for specificity of results, we included a second control
group of participants suffering from BPD. BPD is like MDD
a severe psychiatric disorder with an affective component and
impairments in social functioning. However, the evolutionary
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origin of BPD may be very different from that of MDD. Emotional
instability and identity diffusion seem not to be related to social
submission and to de-escalation of conflicts. Even BPD patients
with depressive symptoms usually contribute to conflicts.
Further, it has been suggested that patients with BPD may view
relationships as competitive struggles rather than as collaborative
ventures.29,30
To avoid confounding effects due to gender differences in
competitive behaviour, we included only female participants in
our investigation. Several studies have shown that women avoided
competition more than men although they did not differ in task
performance.28,31 In addition, a study on emotion and competi-
tion showed that male participants exhibited more positive
emotional responses during competition than female participants,
whereas there was no gender difference in emotionality during
cooperation.32
Method
Ethics statement
The study was approved by the by the Kantonale Ethikkommision
(KEK) Bern. Experiments were performed in agreement with this
institution’s statement (Reference number: 260/09), according to
Swiss law and institutional guidelines.
Participants
We administered the experimental tasks to 36 healthy controls,
24 patients with MDD and 17 patients with BPD (Table 1).
All participants were female. The two patient groups and healthy
controls were matched for education level (Table 1). Patients with
MDD and healthy controls were also matched for age. The
patients were Swiss residents and were recruited from the
University Hospital of Psychiatry Bern. The healthy controls
were also Swiss residents and were recruited either from the
administration department of the University Hospital of Psychia-
try Bern or through newspaper ads or public advertisement sheets
placed in surrounding locations.
Participants in the depressed group met DSM-IV Axis I and
II criteria for current (single or recurrent) MDD with a minimum
Beck Depression Inventory (BDI) score33 of 14 (mean score: 26;
Table 1). The exclusion criteria for the MDD group included
significant medical or neurological disorders, head injuries, first-
degree family history of psychoses, dementia, current substance
abuse or substance dependency and clinical instability (i.e. acute
risk for self-harm, or suicidal or violent behaviour). For the BPD
group, exclusion criteria were identical with the exception of
current MDD diagnosis, but not depressive symptoms. The
exclusion criteria for the control participants encompassed current
or past Axis I or Axis II disorders or any Axis I disorder in a first-
degree relative. Detailed medical records of all participants were
assessed. All participants gave written informed consent and were
paid for participation.
In the MDD group, 20 from 24 patients were taking at least
one antidepressant, 9 an antipsychotic, 1 an antiepileptic drug and
3 patients took lithium. In the BPD group, 10 from 17 patients
were taking an antidepressant, 6 an antipsychotic, 5 an anti-
epileptic and 2 were on lithium (see Data supplement for more
detail on psychotropic medication of the participants).
Clinical assessment
In addition to the Structured Clinical Interview for the DSM-IV
(SCID)34 and BDI measures, all participants completed the Beck
Anxiety Inventory (BAI),35 the Montgomery–Asberg Depression
Rating Scale (MADRS);36 the Global Assessment of Functioning
scale (GAF);34 the Zanarini Rating Scale for Borderline Personality
Disorder (ZAN-BPD);37 a questionnaire on socio-demographic char‐
acteristics; and a questionnaire about nicotine/alcohol consumption.
Further, we assessed experienced social support using the
14-item Questionnaire on Social Support (F-SozU K-14).38 This
questionnaire measures how social support (including emotional
support, practical support and social integration) from the social
network is perceived by the participant. Higher values indi‐
cate higher perceived social support. The participants addi‐
tionally reported information about weight, height and physical
disturbances. The study was approved by the regional ethics
Table 1 Demographic and clinical characteristics of the participants
Healthy controls MDD BPD Statistics
Participants, n 36 24 17
Age, years: mean (s.d.) 36.9 (11.9) 43.6 (14.0) 30.5 (11.1) F(2,74)=5.59; P<0.05a
Education-level match, mean (s.d.) 5 (1.9) 4.2 (1.6) 4.1 (1.3) F(2,74)=2.75; P=0.07
ZAN-BPD, mean (s.d.) 0.6 (0.2) 2.3 (3.0) 10.9 (5.9) F(2,74)=65.8; P<0.001b
BDI, mean (s.d.) 1.5 (2.5) 23.1 (11.9) 17.9 (12.7) F(2,74)=48.9; P<0.001c
BAI, mean (s.d.) 2 (2.1) 20.3 (12.7) 14.2 (9.9) F(2,74)=35.01; P<0.001d
MADRS, mean (s.d.) 0.3 (0.6) 22 (8.3) 13.1 (9.9) F(2,74)=80.8; P<0.001e
GAF, mean (s.d.) 88.6 (2.5) 55.1 (12.6) 57.5 (3.1) F(2,74)=115.2; P<0.001f
BMI, mean (s.d.) 22.7 (3.5) 25.7 (7.9) 26.2 (6.8) F(2,74)=2.78; P=0.07
F-SozU, mean (s.d.) 4.5 (0.5) 3.8 (0.7) 3.6 (0.8) F(2,74)=12.84; P<0.001g
ZAN-BPD, Zanarini Rating Scale for Borderline Personality Disorder; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; MADRS, Mongtomery–Asberg Depression Rating Scale;
GAF, Global Assessment of Functioning scale; BMI, body mass index; F-SozU, Social Support Questionnaire; MDD, major depressive disorder; BPD, borderline personality disorder.
a. Post hoc testing: patients with MDD were significantly older than patients with BPD (t(39)=3.21; P<0.003). There were non-significant trends for differences in age between healthy
controls and MDD (t(58)=−1.97; P=0.05) and healthy controls and BPD groups (t(51)=1.87; P=0.07).
b. Post hoc testing: patients with depression had a higher ZAN-BPD score than the healthy controls (t(58)=4.4; P<0.001), but their score was lower than that of the BPD group
(t(39)=−6.09; P<0.001).
c. Beck Depression Inventory (BDI) had 21 items that were rated on a scale from 0 to 3. Responses were added to a sum score, which had a maximum of 63. A high score indicates
severe depressive symptoms. A score below 20 reflects mild depression, a score above 30 a severe depression. Post hoc testing: in comparison with the healthy group, the BDI
scores were higher in the MDD group (t(58)=−8.49; P<0.001). The trend for a difference in the BDI scores between the MDD and the BPD groups did not reach statistical significance
(t(39)=1.72; P=0.09).
d. Beck Anxiety Inventory (BAI) had 21 items that were rated on a scale from 0 to 3. Responses were added to a sum score, which had a maximum of 63. A high score indicates severe
anxiety symptoms. A score below 21 reflects low anxiety, a score above 35 severe anxiety. Post hoc testing: in the MDD group, the BAI scores were higher in comparison with the
healthy group (t(58)=−10.51; P<0.001). However, the BAI scores were not significantly different between the MDD and BPD groups (t(39)=1.67; P=0.1).
e. Post hoc testing: MADRS scores were significantly higher in the MDD group than in the healthy group (t(58)=−15.59; P<0.001) and the BPD group (t(39)=−3.12; P<0.005).
f. Post hoc testing: although the GAF score was higher for healthy controls than for the patients with MDD (t(58)=15.5; P<0.001), there were no differences in GAF scores between the
BPD and MDD groups (t(39)=−0.61; P=0.55). The GAF score of 88.6 points for the healthy group indicated absence of or minimal symptoms and good functioning in all areas. The
average score of 55.1 points of the patients with MDD indicated the presence of moderate difficulties in social or occupational functioning.
g. Post hoc testing: social support as measured by the F-SozU was higher in healthy controls than in BPD (t(51)=4.7; P<0.001) or MDD (t(58)=4.07; P<0.001). There was, however, no
difference in social support between BPD and MDD (t(39)=−1.1; P=0.27).
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committee (Kantonale Ethikkomission Bern) and was conducted
in accordance with the Declaration of Helsinki.
Procedure
The investigation reported here was part of a larger project with a
series of experiments in which several aspects of social behaviour
(risk, trust and punishment) were investigated using different
experimental tasks. In our study, each participant was matched
with an opponent and could make the decision to choose between
a cooperative and a competitive payment scheme before perform-
ing the actual task.
Once the participant chose her scheme, she performed a real
task. We decided to use a simple motor paper-folding task which
did not require complex cognitive resources. The task involved
folding as many DIN-A4 papers as possible and then inserting
them into DIN-C5 envelopes within a 5-min period. For every
packed envelope, the participants received 1 monetary unit. If the
participant chose the cooperative payment scheme, she received
the average amount of all monetary units gained by both players.
If she chose the competitive payment scheme, her performance
was compared with the opponent’s performance. The participant
received 0 monetary unit if she packed fewer envelopes than her
opponent, and received all monetary units gained by both players
plus an additional 50% of the total amount if she packed more
envelopes than her opponent. At the end of the experiment, all
monetary units were converted into Swiss Francs (1 monetary
unit=0.2 CHF) and reimbursed, together with a show-up fee.
Before making the decision, the participants were informed
about their opponent’s status. The opponent could either be
healthy or have an unknown medical or psychiatric condition
(Experiment I), or could have the same psychiatric diagnosis as
the participant (Experiment II). Thus, in Experiment II, healthy
control participants were matched with healthy opponents, patients
with MDD with an opponent suffering from MDD and patients
with BPD with fellow patients with BPD. The two experiments
were presented in a random order.
To assess the emotional responses to all possible outcomes of
the cooperative and competitive situations, we used six fictitious
scenarios at the end of the experiment (see Table 2 and a detailed
description in the Data supplement). These scenarios included
winning a competition against unknown and same opponents,
losing competition against unknown and same opponents and
cooperation against an unknown opponent with the outcome of
folding either more or less envelopes than the opponent. The
participants were asked to imagine themselves in each of these
scenarios and indicate their experienced emotions on an adapted
version of the Positive and Negative Affect Schedule (PANAS)
from Watson et al.39
Statistical analysis
IBM SPSS Statistics 20 was used for all analyses. For clinical data
analysis, we ran an analysis of variance (ANOVA) with age, edu‐
cation, BDI scores, BAI scores, MADRS scores, BMI scores, F-SozU
scores and GAF scores as the dependent variables and participant
group (healthy, BPD or MDD) as the independent variable.
A Pearson’s chi-squared test was used to determine whether
participants’ competitiveness (choice of the competition or coop-
eration payoff scheme) depended on (a) participants’ mental status
(MDD, BPD or healthy) and (b) the diagnosis of the opponent
(same/unknown or no diagnosis). We first tested the difference in
competitive preferences between the patients with MDD and
healthy participants by performing two Pearson’s chi-squared tests
using the variables payoff scheme and opponent diagnosis for the
match with the unknown opponent (Experiment I) and the second
test for the match with the opponent who had the same mental
status (Experiment II). Two additional chi-squared tests were
conducted to test the difference in competitive preferences for
both opponent types between the MDD and BPD groups.
In every participant group, we used t-tests to examine whether
opponent type (same/unknown or no diagnosis) biased the
participant’s decision to cooperate or not.
To test for the difference in the performance of the paper-
folding task, we conducted an ANOVA on the number of packed
envelopes across the MDD, healthy and BPD groups as well as a
more powerful t-test between the MDD and the healthy groups.
We further analysed whether the task performance depends
on the participants’ competitive preferences. To this end, we
conducted a t-test to compare the outcomes of the competitors
and the cooperators in every participant group and across all
participants, for both matching with an opponent with the same
diagnosis or one having an unknown diagnosis.
To investigate whether depressive symptoms correlated with
the competitive behaviours of the patients with MDD, we con‐
ducted independent paired samples t-tests on the BDI, BAI and
MADRS scores between those participants who chose cooperation
(cooperators) and those who chose competition (competitors)
when matched with both the opponent with the same diagnosis
and the opponent with an unknown, or no, diagnosis.
Results
Demographic and clinical characteristics
We included 24 patients with MDD, 17 patients with BPD and 36
healthy controls (all female). Table 1 shows the sample’s clinical
characteristics. Education level was measured using a rating scale
ranging from 0 (no school finished) to 9 (high university degree).
From the healthy group, 22 participants were single, 11 married
and 3 divorced. From the depressed group, 10 were single,
4 married, 9 divorced and 1 was a widow. From the BPD group,
13 were single, 2 married and 2 divorced. Further, 83% of healthy
participants, 50% of patients with depression and 47% of patients
with BPD were employed, at least partly. As a result of our
matching, the MDD and healthy control groups did not differ
significantly in either age or education. All three groups did not
Table 2 Clinical scores and negative affect scores for the patients with MDD
Same opponent Unknown opponent
Competitors Cooperators t-test Competitors Cooperators t-test
BDI, mean (s.d.) 23.4 (2.4) 33.9 (3.1) t(22)=2.47; P<0.05 24.8 (2) 38 (6.8) t(22)=2.21; P<0.05
BAI, mean (s.d.) 17.1 (2.4) 28.3 (6.1) t(22)=−2.11; P<0.05 17.05 (1.9) 43.3 (7.5) t(22)=4.61; P<0.001
MADRS, mean (s.d.) 19.6 (1.4) 27.9 (4.1) t(22)=−2.43; P<0.05 21.5 (1.7) 25.6 (7.3) t(22)=−0.81; P=0.43
GAF, mean (s.d.) 59.3 (2.3) 44.7 (4.9) t(22)=2.99; P<0.01 55.5 (2.9) 52 (6.1) t(22)=−0.4; P=0.69
Negative affect, mean (s.d.) 3.7 (2.1) 4.5 (7.5) t(22)=−1.45; P=0.16 6.1 (6) 2.3 (2.7) t(22)=−2.49; P<0.05*
BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; MADRS, Mongtomery–Asberg Depression Rating Scale; GAF, Global Assessment of Functioning scale.
*Statistics for this test are reported for Welch’s t-test, since the variances for negative affect were unequal.
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differ regarding trust and non-social risk taking as determined by
simple economic games (see Data supplement for details).
Competitive behaviour
When the patients with depression were matched with an
opponent with an unknown or no diagnosis, only 13% of them
decided to be competitive (see Fig. 1 for the payment scheme
preferences for the three participant groups). However, more than
half of the participants in the healthy group (53%) decided to
compete, leading to a significant difference in choice behaviour
(χ2 (1, 60)=10.1; P<0.005) (Fig. 1a).
In comparison with the BPD group, in which 41% of the
patients chose to compete, the patients with depression avoided
competition more often (χ2 (1, 41)=4.44; P<0.05) (Fig. 1a).
Interestingly, the patients with MDD who chose cooperation
(cooperators) indicated significantly more depressive (t(22)=2.21;
P<0.05) and anxiety symptoms (t(22)=4.61; P<0.001) than those
who chose competition (competitors, Table 2). Within patients
with MDD, antidepressants as estimated by imipramine equiva-
lents were negatively associated with competition avoidance (t(22)
=−2.29; P<0.05); other psychotropic medications were not asso-
ciated with participants’ decisions (see Data supplement).
The choice of payment scheme considerably differed when
patients with depression were informed that their opponent also
suffered from MDD. In this case, 70% of the patients with
depression decided to compete, in contrast to 33% of the
healthy individuals who were matched with another healthy
person (χ2 (1,60)=8.11; P<0.005) (Fig. 1b). However, there were
no differences in competitive behaviours between the MDD and
BPD groups, in which about 70% of the patients decided to
compete with their opponents who had the same diagnosis (χ2
(1,41)=0; P=0.98).
Type of opponent (unknown v. same diagnosis) had a
significant effect on the cooperation/competition decisions of
patients with MDD (t(23)=4.37; P<0.001), whereas its influence
on decisions did not reach statistical significance in healthy
controls (t(35)=−1.75; P=0.09) or in patients with BPD (t(16)=
1.77; P=0.1).
Task performance and competitive behaviour
The average numbers of packed envelopes did not differ between
diagnostic groups (healthy controls: 17.69; MDD: 15.25; BPD:
16.47; (F(2, 76)=2.09; P=0.13)). The direct t-test between the
healthy and the MDD groups showed a trend, which did not reach
statistical significance (t(58)=1.96; P=0.06).
There was no correlation between the choice of payment
scheme and task performance for any of the participant groups.
The lowest P-value for the t-tests comparing task outcome be‐
tween the competitors and the cooperators in every group, and for
both opponent types, was (t(22)=−1.88; P=0.07). However, when
all three groups were included in the analysis, the competitors
showed a better performance than the cooperators when matched
with an unknown participant (t(75)=−2.69; P<0.01). When
matched with an opponent with the same diagnosis, this effect
was not significant (t(75)=−0.83; P=0.41).
Discussion
We investigated the competitive behaviour of patients with
depression using a paradigm based on the social competition
hypothesis, which is a leading theory on the social evolutionary
origins of depression.20 According to this theory, MDD leads to a
subordinate strategy, creating a subjective sense of incapacity and,
therefore, competition avoidance. In this way, patients suffering
from depression communicate to fellow human beings a non-
combative status in whatever social competition situation they
may find themselves in. Their depressive states enable the indi‐
viduals to accept defeat in ritual agonistic encounters and prevent
them from sustaining possible injuries resulting from competing
with stronger individuals.
Summary and interpretation of results
Consistent with our hypothesis, when matched with an unknown
opponent, patients with depression avoided competition much
more often than did the healthy controls and patients with BPD,
although no significant differences existed among the groups in
task performance. This is consistent with the depressed people’s
belief that they are losing the competitions for social life nece‐
ssities such as support, acceptance and care, and they commonly
see this loss as being a result of their own undesirable qualities.40
However, in contrast to our hypothesis, compared with the healthy
group, depressive participants chose the competition payment
scheme more often than did the healthy individuals when matched
with a same-diagnosis opponent. Fictitious scenarios (see Data
supplement) have shown that participants who decided to compete
against the unknown opponent experienced more negative emo-
tions in the case of a fictitious loss than did those who chose
cooperation, indicating that avoiding competition was not simply
driven by anticipation of negative emotions. We additionally de‐
monstrated that neither self-esteem (as indicated in the self-report)
nor non-social risk preferences influenced their decisions (see Data
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Fig. 1 Payment scheme preferences for the three participant groups. The ﬁgure on the left depicts the payment scheme preference of the healthy
participants, patients with MDD and patients with BPD when matched with an opponent with an unknown diagnosis. The right ﬁgure depicts this
same preference for the match with an opponent who has the same diagnosis. The light grey bars represent the percentage of participants who
chose competition, and the dark grey bars represent the percentage of participants who preferred cooperation.
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supplement). However, we showed that in the MDD group, the
severity of depressive and anxiety symptoms positively correlated
with competition avoidance. Although the patients with BPD in
the current sample also had relatively high levels of depressive
symptoms, the presence of these symptoms was not associated with
competition avoidance as seen in the case of MDD. The high level
of depressive symptoms may reflect the recruitment of patients with
BPD from in-patients settings, given that BPD is associated with
persistent depressive symptoms.41 The patients with BPD in the
present experiment had an average BAI-score of 14.2 (9.9), which
according to the BAI-Manual42 can be evaluated as mild anxiety
symptoms (ranging from 0 to 21). This level of anxiety symptoms is
comparable with those found in other clinical studies. For example,
in a psychotherapy treatment trial, the patients with BPD in two
different treatment groups had an average baseline score of 18.6
(9.0) and 23.7 (11.2) respectively,43 corresponding to moderate
anxiety symptoms. In another BPD psychotherapy treatment trial,
both BPD treatment groups had an average score of 20.4 (3.5) and
19.3 (3.6), respectively.44 The BDI score of 17.9 (12.7) in our BPD
sample indicates light depression according to the BDI manual.33 In
the two studies mentioned above, the patients with BPD had more
severe depressive symptoms than in our sample: 31.5 (10.7) and
37.5 (10.6),43 as well as 27.8 (6.1) and 27.6 (5.3).44 However,
another study has found lower BDI scores of 12.3 (4.58) in
adolescent suicide attempters suffering from BPD.45 We considered
the patients with BPD with high levels of depressive symptoms as a
particularly interesting control group, which would enable us to
show that not all kinds of depressive symptoms relate to Price’s
social competition theory. Patients with BPD, even with depressive
symptoms, are frequently involved in ongoing hierarchy conflicts.
However, their depressive symptoms seem not to be associated with
social submission and de-escalation of conflicts.
Interestingly, depressive and anxiety symptoms (as measured
by the BDI and the BAI) of our participants were positively
correlated with competition avoidance. These results argue for a
primary, direct relationship between depressive symptoms occur-
ring in MDD and competition avoidance, as suggested by the
social competition theory.20 To evaluate the influence of emo-
tional responses to competition, we assessed emotional affect in
several fictitious game scenarios. The expected negative emotions
in the case of losing seem not to be responsible for the decision
against competition, since in the MDD group, competitors
reported being more sensitive to losing than the cooperators.
Interestingly, we have found a statistical trend for lower positive
affect in the MDD group in comparison with the healthy control
group in the case of fictitious winning against the opponent with
the same diagnosis. This suggests a decreased positive response of
the reward system,46 which might underlie a failure to maximise
potential monetary earnings in patients with MDD.47,48
Contrary to our expectations, we did not see a pattern of
competition avoidance when patients with depression were
matched with patients having the same diagnosis. Thus, when
matched with an opponent who is supposed to have similar
constraints, patients with depression are more likely to choose
competition. First, this indicates that the patients with MDD hold
different beliefs about the relative abilities of their opponents.
Second, the increased competitiveness of the patients with MDD
against opponents with the same diagnosis may reflect the desires
of the patients with depression to compete in situations with lower
social risks. Therefore, although MDD has been associated with
social competition avoidance,18,20 patients with depression might
not be simply preventing competitive situations; rather, they may
adjust their behaviour to the given circumstances and opponents.
Thus, competitive behaviour can be modulated not only by
competitiveness but also by other factors, like internal representa-
tions of the rival/opponent.
The tendency of individuals with MDD to compete against
patients with a same diagnosis is in line with a recent study
claiming that patients with depression have an increased desire to
compete.40 Two other studies suggested that the more insecure
and uncertain people feel in social relationships and in their
abilities to create a positive image in the minds of others, the more
competitive is their orientation to social relationships.49,50 Thus, it
has been argued that competition relates to the wish to avoid the
unwanted inferiority feelings associated with being rejected.51,52
Indeed, it has been shown that self-beliefs of inferiority and
submissive behaviours are highly associated with depression in
both clinical and non-clinical populations.53,54 Thus, competitive
behaviour might serve to improve what others think about oneself
and counteract the self-belief of inferiority and the belief that
others also perceive one in a negative light.
In line with our finding that patients with MDD are more
competitive when matched with an opponent with the same
diagnosis, in their original article, Price et al stated that in
depression, only hostility to higher-ranking people is inhibited,
whereas hostility expressed to lower-ranking people is often
increased.20 Thus, one might speculate that opponents with the
same diagnosis could be perceived as lower-ranking individuals.
Increased competition against opponents with the same diagnosis
argues against general competition avoidance in MDD. In fact,
there seems to be a complex dysregulation of competitive behaviour,
which is in line with the later refinements of the social competi‐
tion theory, that is, that MDD is a dysfunctioning involuntary
subordinate strategy.21
Competition avoidance in patients with depression might lead
to important disadvantages in the modern Western society.
Competitive behaviour is ubiquitous, being present in domains
as varied as business, politics, sports and intimate relationships.
The romantic55 and employment marketplaces are inherently
competitive; therefore, less competitive individuals are obviously
at a disadvantage. The reluctance to enter competition that is
necessary for many relationships at work, or in intimate relations,
reduces the opportunities of patients with depression in the
workplace and in romantic interpersonal relationships.
Our findings demonstrate, for the first time, experimental
evidence for competition avoidance in patients with depression
as proposed by the social competition theory.20 In line with this
theory, our analysis showed that in comparison with healthy con‐
trols, patients with depression are less likely to choose competition
when matched with an opponent with an unknown diagnosis,
although there were no differences in either performance or risk
preference. The negative association between competition avoid-
ance and the dose of antidepressants in MDD is in line with animal
work showing that submissive behaviour of animals who are treated
with an antidepressant is significantly reduced.25,26
Our results are also in line with Hagen’s bargaining model of
depression, which assumes that depressive behaviour arises as a
bargaining option in a situation where the individual has no other
obvious means to better his or her situation and seizes the
opportunity to cooperate with another ‘new’ individual.56 There-
fore, the bargaining model and specifically the nonparticipation
hypothesis predict that depressed individuals eagerly take escape
routes from ‘games’ that they find unattractive.56 Moreover, the
depressed symptoms themselves are considered such an escape
route that may be used when one is cornered. However, it has to
be noticed that our behavioural experiment did not allow for
investigating bargaining behaviours because the participant’s
decision did not affect the outcome of the opponent. Further,
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the experiment was based on single decisions in the interaction
with anonymous people without the option to send help signals.
Strengths and limitations
The strength of our paradigm is that it captures a situation that is
well defined and close to real life because it is based on monetary
incentives. The situation is also very controlled; for example, the
learning of the participants’ relative abilities is excluded using
a one-shot game. Since lack of self-confidence of patients with
depression may make them more reluctant to compete, we
selected a short and simple task that both depressed and healthy
individuals should be able to perform equally well. We further
conducted an additional non-social experiment to separate the
social from the non-social risk factors related to competition and
cooperation.
This study had several methodological limitations, one being
the small sample size. Since the study was conducted only with
women, the results may not be generalised to men. Another
limitation is that the study cannot test whether depression is a
cause or an effect of low competitiveness. Although Price et al
suggested that decreased competitiveness is the ‘ultimate’ cause of
depression, it is also possible that patients with depression may
attempt to increase their self-concept by competing in a field
where competition is considered appropriate and encouraged.20
This aspect needs further investigation.
Although our results seem to support the social competition
theory of depression, the patients with MDD might have avoided
the competition because they were able to better predict their
general level of ability in comparison with their opponents. Given
that the decisions of patients with depression for or against
competition did not affect monetary payoffs, one might speculate
that these patients evaluated their relative abilities realistically,
thus supporting the ‘analytic rumination’ hypothesis19,57,56 rather
than the ‘social competition’ hypothesis. The analytic rumination
hypothesis suggests that depression triggers focusing on one’s
problems and trying to analyse complex dilemmas which led to
depression, which on the other hand leads to more accurate
decisions. For example, a recent study has shown that when faced
with the task to hire the best applicant in a simulated computer-
based job search, patients with depression approximated the
optimal search strategy much more closely than the non-
depressed participants did.58 Although this study has a number
of caveats, it seems that in specific situations depression can have
a positive effect on analytical skills.
Finally, one of the limitations is that in the test condition,
the patients with depression are matched with an opponent
having the same diagnosis as they themselves. Thus, it would be
interesting to find out whether being matched with someone with
a psychiatric illness or just having a certain match is driving the
results towards competition. However, that would also suggest
that being paired with a healthy opponent in the case of a healthy
participant should have led to higher competition, which was not
the case. Nevertheless, future research should try to replicate our
findings using an additional group of patients with a different
psychiatric condition as a second control.
In summary, our findings show that MDD is associated
with dysregulation of competitive behaviour unrelated to risk
preference. Our results are in line with the evolutionary-based
social competition theory20 and may have important implications
for future research and patient care.
Implications for therapy and future research
Our data encourage more research on the social competition
hypothesis of depression. Longitudinal investigations are needed
to clarify whether competition avoidance is rather a cause or a
consequence of depression, and how much it varies over time.
Competition avoidance may turn out to be a helpful marker in
depression to predict response to psychological and pharmacolo-
gical treatments. For example, testosterone has been proved to be
an antidepressant treatment.59–62 In healthy males, an increase in
testosterone levels as a response to losing enhanced motivation
to compete again.63 As a result, testosterone may be particularly
effective in patients with depression and with pronounced
competition avoidance. In children, competition avoidance might
represent a marker of increased depression risk. Psychological inter‐
ventions to improve motivation to compete may help to prevent
the development of depression later in life. The neural substrate of
competition avoidance can be measured using functional MRI.
Such research will provide new insights into the pathophysiology
of depression. Because Price’s hypothesis is related to genetic risk,
behavioural and neural measures of competition avoidance have
the potential to be useful endophenotypes in MDD.64,65
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